Fundraising Fox

Neuro-Kinesis

Inglewood, US · Delaware corporation

Neuro-Kinesis develops next-generation surgical tools that integrate biosensor technology to give physicians and surgeons real-time environmental monitoring during procedures. Its products include the Huygens smart catheter and Proteus robotic arm surgical platform aimed at improving patient surgical outcomes.

Founders & leadership

EGEli Gang
Eli GangDirector, Chief Electrophysiology Officer
JS
Josh ShacharExecutive Chairman, Chief Technology Officer
CB
CHRISTOPHER BISSELLCHIEF FINANCIAL OFFICER
FA
Frank AdellDirector, President and CEO

Board

DT
Dr. Thomas Chen, MD, PhDBoard director

Reported raises · per SEC filings

Form D private placements

$551K disclosed across 4 rounds · 2020–2026

$51KraisedApr 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eli GangExecutive Officer, Director
  • Dr. Thomas Chen, MD, PhDDirector
  • Josh ShacharExecutive Officer, Director
  • CHRISTOPHER BISSELLExecutive Officer
Offering amount
$2M
Amount sold
$51K
Minimum investment
$10K
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$400KraisedJul 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dr. Thomas Chen, MD, PhDDirector
  • Eli GangExecutive Officer, Director
  • Josh ShacharExecutive Officer, Director
  • Frank AdellExecutive Officer, Director
Offering amount
$400K
Amount sold
$400K
Minimum investment
$400K
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$50KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank AdellExecutive Officer, Director
  • Dr. Thomas Chen, MD, PhDExecutive Officer, Director
  • Josh ShacharExecutive Officer
  • Eli GangExecutive Officer, Director
  • Christopher BissellExecutive Officer
Offering amount
$1M
Amount sold
$50K
Minimum investment
$50K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$50KraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dr. Thomas Chen, MD, PhDExecutive Officer, Director
  • Josh ShacharExecutive Officer
  • Frank AdellExecutive Officer, Director
  • Eli GangExecutive Officer, Director
  • Christopher BissellExecutive Officer
Offering amount
$5M
Amount sold
$50K
Minimum investment
$30K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Neuro-Kinesis for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Neuro-Kinesis do?
Neuro-Kinesis develops next-generation surgical tools that integrate biosensor technology to give physicians and surgeons real-time environmental monitoring during procedures. Its products include the Huygens smart catheter and Proteus robotic arm surgical platform aimed at improving patient surgical outcomes.
How much funding has Neuro-Kinesis raised?
Neuro-Kinesis has disclosed $551K raised across 4 rounds.
Where is Neuro-Kinesis headquartered?
Neuro-Kinesis is headquartered in Inglewood, US.